Overview

Network Osteoporosis Study

Status:
Unknown status

Trial end date:
2007-02-01

Target enrollment:

Participant gender:

Summary

This study is evaluating the use of the drug alendronate in preventing or reversing bone loss in children and adolescents receiving steroid medications.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Glaser Pediatric Research Network

Collaborator:

Elizabeth Glaser Pediatric AIDS Foundation

Treatments:

Alendronate